Clinical trial Recruiting at 7 sites Observational Ages 18 and up

Registry for the Pounce Thrombectomy System in treating blood clots

Official title: Pounce™ Thrombectomy System Retrospective Registry

Run by SurModics, Inc. · NCT05868161 · Data updated 2026-11-12

This study looks at how well the Pounce Thrombectomy System works for removing blood clots in patients with peripheral artery disease and acute limb ischemia who have had a specific procedure done.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorSurModics, Inc.
Industry-sponsored
Locations9 sites (Peoria, Illinois and 8 other locations)
StatusRecruiting
StartedApril 18, 2023
Main results expectedMay 31, 2026
Study endsJuly 31, 2026
Registry record updatedSeptember 11, 2025
Trial IDNCT05868161 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are patients who have undergone an endovascular intervention involving the Pounce Thrombectomy System and can provide informed consent.

Probably not a fit

Patients under the age of 18 years will not benefit from this study as they are excluded from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects data on the use of the Pounce Thrombectomy System, which is designed for the non-surgical removal of blood clots in patients with peripheral arterial disease and acute limb ischemia. The study involves multiple centers across the United States and focuses on patients who have undergone an endovascular intervention where this system was attempted. By analyzing the outcomes of these procedures, the registry aims to provide insights into the effectiveness and safety of the Pounce system.

Why it matters

Potential benefit: If successful, this registry could enhance treatment options for patients suffering from peripheral arterial disease and improve outcomes related to blood clot removal.

How similar studies have gone: While this registry is focused on a specific device, similar observational studies have shown success in evaluating the effectiveness of thrombectomy systems in treating vascular conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted
* Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place

Exclusion Criteria:

* Subject is under the age of 18 years

Where it's running

  • OSF St. Francis Medical Center
    Peoria, Illinois, United States
    Recruiting
  • Baton Rouge General Medical Center
    Baton Rouge, Louisiana, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Prisma Health Upstate
    Greenville, South Carolina, United States
    Recruiting
  • North Central Heart
    Sioux Falls, South Dakota, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting
Show 3 more locations
  • Ascension Seton
    Austin, Texas, United States
    Recruiting
  • Community Hospital
    Munster, Indiana, United States
    Completed
  • Allina Health
    Minneapolis, Minnesota, United States
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.